Biocon Limited
BIOCON
Rangering i aksjer
#3397
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Aksjekurs
$3.75
Sist synkronisert: 2026-10-19
Markedsverdi
$5.13B
Endring (1 dag)
-2.30%
Endring (1 år)
-9.49%
Land
IN
Handel Biocon Limited (BIOCON)
Kategori
Healthcare
Historikk for aksjesplitt for Biocon Limited (BIOCON)
Aksjen Biocon Limited (symbol: BIOCON) har gjennomgått totalt 3 aksjesplitt.
Den nyeste splittelsen skjedde Jun 12, 2019.
Én BIOCON-aksje kjøpt før Sep 11, 2008 tilsvarer i dag 12 BIOCON-aksjer.
Den nyeste splittelsen skjedde Jun 12, 2019.
Én BIOCON-aksje kjøpt før Sep 11, 2008 tilsvarer i dag 12 BIOCON-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| 2019-06-12 | 2:1 | x2 | x12 |
| 2017-06-15 | 3:1 | x3 | x6 |
| 2008-09-11 | 2:1 | x2 | x2 |
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
